Evidence map›Paper›PMID 31792363›Full record

ArticleMolecular psychiatry2021

Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder.

Kevin S O'Connell, Alexey Shadrin, Shahram Bahrami, Olav B Smeland, Francesco Bettella, Oleksandr Frei, Florian Krull, Ragna B Askeland, G Bragi Walters, Katrín Davíðsdóttir and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. The Regulatory Potential of Long Non-Coding RNAs in Bipolar Disorder.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. ADHD symptom trajectories across childhood and early adolescence and risk for hypomanic symptoms in young adulthood.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kevin S O'ConnellNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway. kevin.oconnell@medisin.uio.no.ORCID http://orcid.org/0000-0002-6865-8795
Alexey ShadrinNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway.
Shahram BahramiNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway.
Olav B SmelandNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway.ORCID http://orcid.org/0000-0002-3761-5215
Francesco BettellaNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway.ORCID http://orcid.org/0000-0001-7968-8642
Oleksandr FreiNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway.
Florian KrullNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway.
Ragna B AskelandDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
G Bragi WaltersdeCODE genetics/Amgen, Reykjavík, Iceland.ORCID http://orcid.org/0000-0002-5415-6487
Katrín DavíðsdóttirThe Centre for Child Development and Behaviour, Capital Area Primary Health Care, Reykjavik, Iceland.
Gyða S HaraldsdóttirThe Centre for Child Development and Behaviour, Capital Area Primary Health Care, Reykjavik, Iceland.
Ólafur Ó GuðmundssondeCODE genetics/Amgen, Reykjavík, Iceland.ORCID http://orcid.org/0000-0001-8466-1559
Hreinn StefánssondeCODE genetics/Amgen, Reykjavík, Iceland.ORCID http://orcid.org/0000-0002-9331-6666
Chun C FanDepartment of Radiology, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID http://orcid.org/0000-0001-9437-2128
Nils Eiel SteenNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway.
Ted Reichborn-KjennerudDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
Anders M DaleDepartment of Radiology, University of California, San Diego, La Jolla, CA, 92093, USA.
Kári StefánssondeCODE genetics/Amgen, Reykjavík, Iceland.ORCID http://orcid.org/0000-0003-1676-864X
Srdjan DjurovicDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-8140-8061
Ole A AndreassenNORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, 0407, Oslo, Norway. ole.andreassen@medisin.uio.no.ORCID http://orcid.org/0000-0002-4461-3568

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differential diagnosis between childhood onset attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BD) remains a challenge, mainly due to overlapping symptoms and high rates of comorbidity. Despite this, genetic correlation reported for these disorders is low and non-significant. Here we aimed to better characterize the genetic architecture of these disorders utilizing recent large genome-wide association studies (GWAS). We analyzed independent GWAS summary statistics for ADHD (19,099 cases and 34,194 controls) and BD (20,352 cases and 31,358 controls) applying the conditional/conjunctional false discovery rate (condFDR/conjFDR) statistical framework that increases the power to detect novel phenotype-specific and shared loci by leveraging the combined power of two GWAS. We observed cross-trait polygenic enrichment for ADHD conditioned on associations with BD, and vice versa. Leveraging this enrichment, we identified 19 novel ADHD risk loci and 40 novel BD risk loci at condFDR <0.05. Further, we identified five loci jointly associated with ADHD and BD (conjFDR < 0.05). Interestingly, these five loci show concordant directions of effect for ADHD and BD. These results highlight a shared underlying genetic risk for ADHD and BD which may help to explain the high comorbidity rates and difficulties in differentiating between ADHD and BD in the clinic. Improving our understanding of the underlying genetic architecture of these disorders may aid in the development of novel stratification tools to help reduce these diagnostic difficulties.

Indexed as

Attention Deficit Disorder with HyperactivityBipolar DisorderChildGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPolymorphism, Single Nucleotide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.